Todd Foley
Director at Aktis Oncology, Inc. (AKTS); 10% Owner at Entrada Therapeutics, Inc. (TRDA)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-14.3%
vs. S&P 500-15.1%
Beat the market0%
Paper profit on buys+$35K
Total bought / sold$4.2M / $462K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 26SEC | TRDAEntrada Therapeutics, Inc. | Sell | 21,6234,359,439 held (−0%) | $7.34 | $159K | -22.8% |
| Aug 26SEC | TRDAEntrada Therapeutics, Inc. | Sell | 26,5224,332,917 held (−1%) | $7.54 | $200K | -24.8% |
| Aug 26SEC | TRDAEntrada Therapeutics, Inc. | Sell | 14,5694,318,348 held (−0%) | $7.06 | $103K | -19.7% |
| Jan 14SEC | AKTSAktis Oncology, Inc. | Buy | 232,8704,235,403 held (+6%) | $18.00 | $4.2M | +0.8% |
- Buy
Director Todd Foley bought $4.2M of AKTS at $18.00 — first open-market purchase in our records.